Chapel Hill Pharma Cempra Prices IPO

Chapel Hill-based pharmaceutical company Cempra has priced its upcoming initial public offering at between $11 and $13 a share, according to a Jan. 13 filing with the U.S. Securities and Exchange Commission.
Triangle Business Journal